Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04689867 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04689867 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 5 participants.
The verdict
NCT04689867, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study, CBSPp will be tested in an initial open trial (n = 10) to examine its feasibility and acceptability. Investigators will recruit clients receiving services at a community mental health setting who have a schizophrenia spectrum disorder and recent suicidal thoughts and behaviors to receive the behavioral intervention for 10-weeks. Providers will be recruited and trained to deliver the intervention. Both clients and providers will be assessed at baseline to test our approach to measurement prior to the Aim 2 RCT (registered separately). Clients will be assessed at three additional timepoints (middle of treatment, end of treatment, and 2 months after treatment ends.
Interventions
- BEHAVIORAL Cognitive Behavioral Suicide Prevention for psychosis CBSPp)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-04-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04689867
The ClinicalTrials.gov registry entry for NCT04689867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Suicide Prevention for psychosis CBSPp) is the first listed.
NCT04689867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04689867 about?
NCT04689867 is a clinical study titled "Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1". The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study, CBSPp will be tested in an initial open trial (n = 10) to examine its feasibility and acceptabilit...
What is the current status of trial NCT04689867?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-09-01. Estimated completion is 2022-04-11.
What interventions are being tested in trial NCT04689867?
The interventions under investigation include: Cognitive Behavioral Suicide Prevention for psychosis CBSPp) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04689867?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.